SER-262 Versus Placebo in Adults With Primary Clostridium Difficile Infection to Prevent Recurrence
Public ClinicalTrials.gov record NCT02830542. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 1b Randomized, Double-Blind, Placebo-Controlled, Ascending Single and Multiple Dose Study to Evaluate the Safety, Tolerability and Efficacy of SER-262 in Adults With Primary Clostridium Difficile Infection (CDI) to Prevent Recurrence
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The study will involve administering a single dose of investigational drug or placebo in ascending dose cohorts. This study is designed to evaluate the safety and tolerability of investigational drug as well as the efficacy of investigational drug versus placebo in adults with primary (first episode) Clostridium difficile infection (CDI).
Study identification
- NCT ID
- NCT02830542
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 1
- Enrollment
- 96 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Aug 2016 (Actual)
- Primary completion
- May 2018 (Actual)
- Completion
- Aug 2018 (Actual)
- Last update posted
- Feb 6, 2023
2016 – 2018
United States locations
- U.S. sites
- 22
- U.S. states
- 17
- U.S. cities
- 22
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| North Alabama Research Center, LLC | Athens | Alabama | 35749 | — |
| Lalla-Reddy Medical Corporation | Fountain Valley | California | 92708 | — |
| eStudySite | La Mesa | California | 91942 | — |
| San Marcus Research Clinic, Inc. | Miami | Florida | 33015 | — |
| Omega Research Consultants | Orlando | Florida | 32810 | — |
| Emory University Hospital | Atlanta | Georgia | 30322 | — |
| Clinical Research Atlanta | Stockbridge | Georgia | 30281 | — |
| Snake River Research | Idaho Falls | Idaho | 83404 | — |
| Anne Arundel Health System Research Institute | Annapolis | Maryland | 21401 | — |
| Henry Ford Health System | Detroit | Michigan | 48202 | — |
| Mayo Clinic | Rochester | Minnesota | 55902 | — |
| Sundance Clinical Research, LLC | St Louis | Missouri | 63141 | — |
| Mercury St. Medical Group | Butte | Montana | 59701 | — |
| Quality Clinical Research | Omaha | Nebraska | 68114 | — |
| Jersey Shore University Medical Center | Neptune City | New Jersey | 07753 | — |
| University of Rochester Medical Center | Rochester | New York | 14642 | — |
| Montefiore Medical Center | The Bronx | New York | 10467 | — |
| Remington Davis | Columbus | Ohio | 43215 | — |
| Regional Infectious Diseases & Infusion Center | Lima | Ohio | 45801 | — |
| Baylor Scott & White Research Institute | Temple | Texas | 76508 | — |
| Dr. Hansen Internal Medicine | Bountiful | Utah | 84010 | — |
| Infectious Disease Associates of Central Virginia | Lynchburg | Virginia | 24501 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02830542, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Feb 6, 2023 · Synced Oct 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT02830542 live on ClinicalTrials.gov.